Medicament for treating mesangial proliferative glomerulonephritis
A technology for glomerulonephritis and hyperplasia, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of easy to cause other diseases, unsuitable for long-term use, and large side effects, etc., to achieve abundant drug sources, easy production, and low side effects small effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0019] The present invention will be further described below in conjunction with the examples.
[0020] The medicine for treating mesangial proliferative glomerulonephritis disclosed by the present invention consists of the following traditional Chinese medicines in parts by weight: 8-9 parts of Radix Astragali, 1-2 parts of Panax notoginseng, 2-3 parts of Eclipta, 2 parts of Shengdi -3 parts, Angelica 1-2 parts, Ejiao 1-2 parts, Hedyotis diffusa 2-3 parts, Imperata 2-3 parts, Motherwort 2-3 parts, Rubia 1-2 parts, Rhubarb 1-2 parts, Poria 1-2 parts, Alisma 1-2 parts, Rehmannia glutinosa 1-2 parts, Ligustrum lucidum 2-3 parts, Cuscuta 1-2 parts, Eclipta 1-2 parts, Eucommia 1-2 parts.
[0021] As a preferred solution: the drug is composed of the following traditional Chinese medicines in parts by weight: 90 grams of astragalus, 20 grams of Panax notoginseng, 30 grams of Eclipta chinensis, 30 grams of habitat, 20 grams of angelica, 20 grams of donkey-hide gelatin, 30 grams of He...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More